Skeletal muscle stem cells confer maturing macrophages anti-inflammatory properties through insulin-like growth factor-2. (16th March 2020)
- Record Type:
- Journal Article
- Title:
- Skeletal muscle stem cells confer maturing macrophages anti-inflammatory properties through insulin-like growth factor-2. (16th March 2020)
- Main Title:
- Skeletal muscle stem cells confer maturing macrophages anti-inflammatory properties through insulin-like growth factor-2
- Authors:
- Fang, Jiankai
Zhang, Shengchao
Liu, Zhanhong
Pan, Yongsha
Cao, Lijuan
Hou, Pengbo
Chen, Yongjing
Zhang, Yuyan
Li, Xiaolei
Liu, Rui
Shang, Qianwen
Zheng, Zhiyuan
Song, Lin
Li, Yanan
Fu, Zhonglin
Lin, Liangyu
Melino, Gerry
Wang, Ying
Shao, Changshun
Shi, Yufang - Abstract:
- Abstract: Cytokines produced by immune cells have been demonstrated to act on muscle stem cells (MuSCs) and direct their fate and behavior during muscle repair and regeneration. Nevertheless, it is unclear whether and how MuSCs can also in turn modulate the properties of immune cells. Here, we showed that in vitro expanded MuSCs exhibited a potent anti-inflammatory effect when infused into mice suffering from inflammatory bowel disease (IBD). Supernatant conditioned by MuSCs similarly ameliorated IBD. This beneficial effect of MuSCs was not observed when macrophages were depleted. The MuSC supernatant was found to greatly attenuate the expression of inflammatory cytokines but increase the expression of programmed death-ligand 1 in macrophages treated with lipopolysaccharide and interferon gamma. Further analysis revealed that MuSCs produce a large amount of insulin-like growth factor-2 (IGF-2) that instructs maturing macrophages to undergo oxidative phosphorylation and thus acquire anti-inflammatory properties. Interestingly, the IGF-2 production by MuSCs is much higher than by mesenchymal stem cells. Knockdown or neutralization of IGF-2 abrogated the anti-inflammatory effects of MuSCs and their therapeutic efficacy on IBD. Our study demonstrated that MuSCs possess a strong anti-inflammatory property and the bidirectional interactions between immune cells and MuSCs have important implications in muscle-related physiological and pathological conditions. : Abstract : ImmuneAbstract: Cytokines produced by immune cells have been demonstrated to act on muscle stem cells (MuSCs) and direct their fate and behavior during muscle repair and regeneration. Nevertheless, it is unclear whether and how MuSCs can also in turn modulate the properties of immune cells. Here, we showed that in vitro expanded MuSCs exhibited a potent anti-inflammatory effect when infused into mice suffering from inflammatory bowel disease (IBD). Supernatant conditioned by MuSCs similarly ameliorated IBD. This beneficial effect of MuSCs was not observed when macrophages were depleted. The MuSC supernatant was found to greatly attenuate the expression of inflammatory cytokines but increase the expression of programmed death-ligand 1 in macrophages treated with lipopolysaccharide and interferon gamma. Further analysis revealed that MuSCs produce a large amount of insulin-like growth factor-2 (IGF-2) that instructs maturing macrophages to undergo oxidative phosphorylation and thus acquire anti-inflammatory properties. Interestingly, the IGF-2 production by MuSCs is much higher than by mesenchymal stem cells. Knockdown or neutralization of IGF-2 abrogated the anti-inflammatory effects of MuSCs and their therapeutic efficacy on IBD. Our study demonstrated that MuSCs possess a strong anti-inflammatory property and the bidirectional interactions between immune cells and MuSCs have important implications in muscle-related physiological and pathological conditions. : Abstract : Immune cells are known to direct the fate of muscle stem cells (MuSCs) during tissue repair and regeneration. MuSCs can also act on maturing macrophages and confer them with anti-inflammatory properties via insulin-like growth factor-2, thus ameliorating dextran sulfate sodium-induced colitis. … (more)
- Is Part Of:
- Stem cells translational medicine. Volume 9:Number 7(2020)
- Journal:
- Stem cells translational medicine
- Issue:
- Volume 9:Number 7(2020)
- Issue Display:
- Volume 9, Issue 7 (2020)
- Year:
- 2020
- Volume:
- 9
- Issue:
- 7
- Issue Sort Value:
- 2020-0009-0007-0000
- Page Start:
- 773
- Page End:
- 785
- Publication Date:
- 2020-03-16
- Subjects:
- anti-inflammation -- IBD -- IGF-2 -- macrophages -- muscle stem cells -- OXPHOS
Stem cells -- Periodicals
Regenerative medicine -- Periodicals
Periodicals
616.0277405 - Journal URLs:
- https://academic.oup.com/stcltm ↗
http://stemcellsjournals.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2157-6580/issues/ ↗
http://stemcellstm.alphamedpress.org/ ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/sctm.19-0447 ↗
- Languages:
- English
- ISSNs:
- 2157-6564
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25857.xml